Oncolytics Biotech Inc T.ONC

Alternate Symbol(s): ONCY

Healthcare Biotechnology

Oncolytics Biotech Inc. is a clinical-stage biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to registration-enabling clinical studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.

TSX:ONC - Post by User

Oncolytics Biotech Inc > buying opportunity

<< Previous

Bullboard Posts

Next >>

Comment by Azzak34on Dec 04, 2024 6:16am

98 Views

Post# 36344504

RE:RE:buying opportunity

Haha Buckster you post multiple times a day on the message board of a stock you don't hold? There must be other things to be doing with your life! Maybe an online grammar and spelling course? Set up a Grindr account and meet exciting new people.

<< Previous

Bullboard Posts

Next >>

A Look into the Future of Chronic Pain Management